{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:28:08Z","timestamp":1777904888800,"version":"3.51.4"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.2169\/internalmedicine.9092-21","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T22:11:16Z","timestamp":1648246276000},"page":"3287-3291","source":"Crossref","is-referenced-by-count":2,"title":["Granulocyte-colony-stimulating Factor-resistant Neutropenia and Polyneuropathy Presenting as Severe Complications of Sj\u00f6gren's Syndrome"],"prefix":"10.2169","volume":"61","author":[{"given":"Katsuyuki","family":"Tomita","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Yonago Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Tokugawa","sequence":"additional","affiliation":[{"name":"Center for Clinical Residency Program, National Hospital Organization Yonago Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genki","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Yonago Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Moriyasu","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Yonago Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Touge","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Yonago Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminari","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, National Hospital Organization Yonago Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sj\u00f6gren H. Zur Kenntnis der Keratoconjunctivitis sicca. Acta Ophthalmol 13: 1-39, 1933.","DOI":"10.1111\/j.1755-3768.1935.tb04186.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Asmussen K, Andersen V, Bendixen G, et al. A new model for classification of disease manifestations in primary Sj\u00f6gren&apos;s syndrome: evaluation in a retrospective long-term study. J Int Med 239: 475-482, 1996.","DOI":"10.1046\/j.1365-2796.1996.418817000.x"},{"key":"3","unstructured":"3. Markusse HM, Oudkerk M, Vroom TM, et al. Primary Sj\u00f6gren&apos;s syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology. Neth J Med 40: 125-134, 1992."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Delalande S, de Seze J, Fauchais A-L, et al. Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine 83: 280-291, 2004.","DOI":"10.1097\/01.md.0000141099.53742.16"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 39: 121-127, 2002.","DOI":"10.1053\/shem.2002.31918"},{"key":"6","unstructured":"6. Won D, Suh J, Kim H. Autoantibody-induced apoptosis of neutrophils in systemic lupus erythematosus patients. Korean J Lab Med 24: 405-414, 2004."},{"key":"7","unstructured":"7. Hwang K, Park C-J, Huh HJ, et al. Flow cytometric detection of neutrophil-associated immunoglobulin in patients with or without neutropenia and establishment of the reference interval. Ann Clin Lab Sci Spring 41: 144-149, 2011."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren&apos;s syndrome. Ann Rheum Dis 76: 9-16, 2017.","DOI":"10.1136\/annrheumdis-2016-210571"},{"key":"9","unstructured":"9. Markusse HM, Oudkerk M, Vroom TM, et al. Primary Sj\u00f6gren&apos;s syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology. Neth J Med 40: 125-134, 1992."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schattner A, Friedman J, Klepfish A, et al. Immune cytopenias as the presenting manifestation in primary Sj\u00f6gren&apos;s syndrome. Q J Med 93: 825-829, 2000.","DOI":"10.1093\/qjmed\/93.12.825"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Lamour A, Le-Corre R, Pennec YL, et al. Heterogeneity of neutrophil antibodies in patients with primary Sj\u00f6gren&apos;s syndrome. Blood 86: 3553-3559, 1995.","DOI":"10.1182\/blood.V86.9.3553.bloodjournal8693553"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bux J, Kissel K, Nowak K, et al. Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 63: 249-252, 1991.","DOI":"10.1007\/BF01698373"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Riera NE, Salt\u00f3 MR, Gal\u00e1n V, et al. Anti-polymorphonuclear neutrophil antibodies in patients with leukopenia or neutropenia. Int J Lab Hematol 32: e96-e105, 2010.","DOI":"10.1111\/j.1751-553X.2009.01173.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lalezari P, Jiang AF, Yegen L, et al. Chronic autoimmune neutropenia due to anti-NA2 antibody. N Engl J Med 293: 744-747, 1975.","DOI":"10.1056\/NEJM197510092931504"},{"key":"15","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood.V94.5.1797","volume":"94","author":"MC Bruin","year":"1999","unstructured":"15. Bruin MC, von dem Borne AE, Tamminga RY, et al. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 94: 1797-1802, 1999.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Henriksson G, Manthorpe R, Bredberg A. Antibodies to CD4 in primary Sj\u00f6gren&apos;s syndrome. Rheumatology 39: 142-147, 2000.","DOI":"10.1093\/rheumatology\/39.2.142"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brito-Zer\u00f3n P, Soria N, Mu\u00f1oz S, et al. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sj\u00f6gren&apos;s syndrome. Semin Arthritis Rheum 38: 389-395, 2009.","DOI":"10.1016\/j.semarthrit.2008.01.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gemignani F, Marbini A, Pavesi G, et al. Peripheral neuropathy associated with primary Sjogren&apos;s syndrome. Neurol Neurosurg Psychiatry 57: 983-986, 1994.","DOI":"10.1136\/jnnp.57.8.983"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Van den Bergh PY, Hadden RD, Bouche P, et al. European federation of neurological societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17: 356-363, 2010.","DOI":"10.1111\/j.1468-1331.2009.02930.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cafaro G, Perricone C, Carubbi F, et al. Peripheral nervous system involvement in Sj\u00f6gren&apos;s syndrome: analysis of a cohort from the Italian research group on Sj\u00f6gren&apos;s syndrome. Front Immunol 12: 615656, 2021.","DOI":"10.3389\/fimmu.2021.615656"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vivancos J, Vila M, Serra A, et al. Failure of G-CSF therapy in neutropenia associated with Sj\u00f6gren&apos;s syndrome. Rheumatology 41: 471-473, 2002.","DOI":"10.1093\/rheumatology\/41.4.471"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yamato E, Fujioka Y, Masugi F, et al. Autoimmune neutropenia with anti-neutrophil autoantibody associated with Sj\u00f6gren syndrome. Am J Med Sci 300: 102-103, 1990.","DOI":"10.1097\/00000441-199008000-00006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lamy T, Dauriac C, Morice P, et al. Agranulocytose et connectivites distinctes du syndrome de Felty: 4 observations. Succ\u00e8s dans un cas de la ciclosporine. Rev Med Interne 11: 325-328, 1990.","DOI":"10.1016\/S0248-8663(05)80868-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84: 304, 1976.","DOI":"10.7326\/0003-4819-84-3-304"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154: 4719, 1995.","DOI":"10.4049\/jimmunol.154.9.4719"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Meagher LC, Cousin JM, Seckl JR, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156: 4422, 1996.","DOI":"10.4049\/jimmunol.156.11.4422"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Franco LM, Gadkari M, Howe KN, et al. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses. J Exp Med 216: 384-406, 2019.","DOI":"10.1084\/jem.20180595"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/21\/61_9092-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:09:33Z","timestamp":1675055373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/21\/61_9092-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":27,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9092-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"9092-21"}}